Repeat MRI two years after the prior (second) resection, and combined chemoradiotherapy, demonstrates a significant reduction of mass effect, and ex-vacuo dilatation of the frontal horn of the lateral ventricle. There has, however, been the development of significant and fairly diffuse heterogeneous enhancement throughout the frontal lobe, with associated increase in CBV. This is in keeping with tumour recurrence / progression.